Effectiveness of adjunctive hyaluronic acid application in coronally advanced flap in Miller class I single gingival recession sites: a randomized controlled clinical trial

Effectiveness of adjunctive hyaluronic acid application in coronally advanced flap in Miller class I single gingival recession sites: a randomized controlled clinical trial
复制标题

DOI:
10.1007/s00784-018-2537-4
复制
发表时间:
2019-03-01
影响因子:
3.4
通讯作者:
Rojas, Mariana A.
Rojas, Mariana A.
中科院分区:
医学2区
文献类型:
--
作者:
Pilloni, Andrea;Schmidlin, Patrick R.;Rojas, Mariana A.

文献摘要

被引文献

相似文献

ObjectiveTheirrandomizedcontrolledclinicaltrial的目的是评估连续性透明质酸(HA)应用于冠状动脉推进皮瓣(CAF)手术在单一米勒I类/退缩1型(RT 1)牙龈退缩treatment.Material and Methods 30例患者一次退缩入组; 15例随机分配CAF + HA和15例单独CAF。18个月后计算后退减少(RecRed)、临床附着水平增加(CAL-增益)、探诊袋深度(PPD)和角化组织宽度(KT)的变化、完全牙根覆盖(CRC)和平均牙根覆盖(MRC)。术后发病率(疼痛强度,不适,肿胀)记录7天后,使用视觉模拟量表(VAS)。结果18个月后,RecRed是统计学显着高于试验组(2.7毫米[1.0])比对照组(1.9毫米[1.0]; p=0.007)。发现两组的PPD轻微但具有统计学显著性增加。两种处理之间KT增加无统计学显著差异。试验部位的CRC为80%,对照部位为33.3%(p
ObjectivesThe aim of this randomized controlled clinical trial was to evaluate the possible advantages of adjunctive hyaluronic acid (HA) application in thecoronally advanced flap (CAF) procedure in single Miller class I/recession type 1 (RT1) gingival recession treatment.Material and methodsThirty patients with one recession were enrolled; 15 were randomly assigned CAF + HA and 15 to CAF alone. The recession reduction (RecRed), clinical attachment level gain (CAL-gain), changes in probing pocket depth (PPD) and in the width of keratinized tissue (KT), complete root coverage (CRC), and mean root coverage (MRC) were calculated after 18months. Post-operative morbidity (pain intensity, discomfort, and swelling) was recorded 7days after treatment using visual analogue scale (VAS).ResultsAfter 18months, RecRed was statistically significantly higher in the test group (2.7mm [1.0]) than in the control group (1.9mm [1.0]; p=0.007). PPD were found to be slightly but statistically significantly increased in both groups. No statistically significant difference was found for KT gain between treatments. CRC was 80% for test and 33.3% for control sites (p